To ascertain the selectivity of MZ1 towards BET family proteins, we treated GBM cells with varying concentrations of MZ1 and assessed the protein levels of BET family proteins, including BRD2, BRD3, and BRD4. This evidence concerns the gene BRD2 and glioblastoma.